Curbing the opioid epidemic in the United States: the risk evaluation and mitigation strategy (REMS)

JAMA. 2012 Aug 1;308(5):457-8. doi: 10.1001/jama.2012.8165.

Authors

Lewis S Nelson¹, Jeanmarie Perrone

Affiliation

¹ Department of Emergency Medicine, New York University School of Medicine, 455 First Ave, Room 123, New York, NY 10016, USA. lewis.nelson@nyumc.org

PMID: 22851109
DOI: 10.1001/jama.2012.8165

No abstract available

MeSH terms

Analgesics, Opioid / adverse effects*
Analgesics, Opioid / poisoning
Drug Overdose / epidemiology
Drug and Narcotic Control / legislation & jurisprudence*
Drug and Narcotic Control / methods
Epidemics*
Government Regulation
Humans
Off-Label Use
Opioid-Related Disorders / epidemiology*
Opioid-Related Disorders / prevention & control*
Pain / drug therapy
Patient Care / standards
Practice Patterns, Physicians'
Product Surveillance, Postmarketing
Risk Assessment*
United States / epidemiology
United States Food and Drug Administration / legislation & jurisprudence

Substances

Analgesics, Opioid